To the Editor: Girgis and Seibel1 are to be congratulated as endocrinologists for raising the important issue of bisphosphonate therapy and femoral fractures. This is a relatively new phenomenon that even a couple of years ago, although already documented, did not seem to be on many endocrinologists’ radar.
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
- Northeast Health Wangaratta, Wangaratta, VIC.
Correspondence: ortho.rooms@bigpond.com
- 1. Girgis CM, Seibel MJ. Atypical femur fractures: a complication of prolonged bisphosphonate therapy [editorial]? Med J Aust 2010; 193: 196-198. <MJA full text>
Online responses are no longer available. Please refer to our instructions for authors page for more information.